Related Experiment Video
Updated: Jul 19, 2025

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
Published on: May 28, 2014
Anti-inflammatory potential of platinum nanozymes: mechanisms and perspectives
Giuseppe Bardi1, Luca Boselli1, Pier Paolo Pompa1
1Nanobiointeractions & Nanodiagnostics, Istituto Italiano di Tecnologia, Via Morego 30, 16163 Genova, Italy. giuseppe.bardi@iit.it.
Abstract:
Inflammation is a complex process of the body in response to pathogen infections or dysregulated metabolism, involving the recruitment and activation of immune system components. Repeated dangerous stimuli or uncontrolled immune effector mechanisms can result in tissue injury. Reactive Oxygen Species (ROS) play key roles in physiological cell signaling as well as in the destruction of internalized pathogens. However, aberrant ROS production and release have deleterious effects on the surrounding environment, making ROS regulation a priority to reduce inflammation. Most of the current anti-inflammatory therapies rely on drugs that impair the release of pro-inflammatory mediators. Nevertheless, increasing the enzymatic activity to reduce ROS levels could be an alternative or complementary therapeutic approach to decrease inflammation. Nanozymes are nanomaterials with high catalytic activity that mimic natural enzymes, allowing biochemical reactions to take place. Such functional particles typically show different and regenerable oxidation states or catalytically reactive surfaces offering long-term activity and stability. In this scenario, platinum-based nanozymes (PtNZs) exhibit broad and efficient catalytic functionalities and can reduce inflammation mainly through ROS scavenging, e.g. by catalase and superoxide dismutase reactions. Dose-dependent biocompatibility and immune compatibility of PtNZs have been shown in different cells and tissues, both in vitro and in vivo. Size/shape/surface engineering of the nanozymes could also potentiate their efficacy to act at different sites and/or steps of the inflammation process, such as cytokine removal or specific targeting of activated leukocytes. In the present review, we analyze key inflammation triggering processes and the effects of platinum nanozymes under exemplificative inflammatory conditions. We further discuss potential platinum nanozyme design and improvements to modulate and expand their anti-inflammatory action.
Insights
Platinum nanozymes (PtNZs) offer a novel therapeutic strategy by scavenging reactive oxygen species (ROS) to reduce inflammation. Engineering PtNZs can enhance their anti-inflammatory effects and target specific inflammatory pathways.
Area of Science:
- Biomedical Engineering
- Materials Science
- Immunology
Background:
- Inflammation is a critical biological response to stimuli but can cause tissue injury if uncontrolled.
- Reactive Oxygen Species (ROS) are key mediators in inflammation, necessitating their regulation for therapeutic benefit.
- Current anti-inflammatory drugs primarily inhibit pro-inflammatory mediator release, highlighting the need for alternative approaches like ROS scavenging.
Purpose of the Study:
- To review the role of platinum-based nanozymes (PtNZs) in modulating inflammation.
- To explore PtNZs' potential as an alternative or complementary therapeutic strategy for inflammation.
- To discuss the design and engineering of PtNZs for enhanced anti-inflammatory efficacy.
Main Methods:
- Review of existing literature on inflammation, ROS, and nanozymes.
- Analysis of platinum nanozyme catalytic activities, particularly ROS scavenging (catalase and superoxide dismutase mimicry).
- Evaluation of in vitro and in vivo biocompatibility and immune compatibility data for PtNZs.
Main Results:
- Platinum nanozymes (PtNZs) effectively reduce inflammation by scavenging ROS.
- PtNZs demonstrate dose-dependent biocompatibility and immune compatibility.
- Engineering PtNZs (size, shape, surface) can improve their targeting and efficacy in inflammatory processes.
Conclusions:
- Platinum nanozymes represent a promising therapeutic avenue for managing inflammation through ROS regulation.
- Further design and engineering of PtNZs can optimize their anti-inflammatory actions and expand their therapeutic applications.
- PtNZs offer a stable and regenerable catalytic approach to combatting inflammation.

